No phaseCompleted

Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)

Sponsor
Kaiser Permanente (Academic or other)
Enrolment
200 enrolled
Conditions
Weight Loss; Diabetes Mellitus, Type 2; Psychotic Disorders
Interventions
Premier Lifestyle Intervention with DASH Diet
Ages
adults, older adults
Registry
NCT00790517

From the registry

The purpose of this study is to examine the effectiveness of a lifestyle intervention designed to reduce weight and diabetes risk in a population of individuals with mental illness who are also taking antipsychotic medications. We will examine the effectiveness of the intervention in 1. reducing weight and Body Mass Index; 2. reducing fasting insulin levels and increasing insulin sensitivity; and 3. reducing total cholesterol and LDL cholesterol.

Primary outcomes

  • Body Mass Index
  • Weight
  • Insulin sensitivity
  • Fasting insulin levels
Full record on ClinicalTrials.gov